Patient Profiles

	Jane Duncan *    PATIENT   FAMILY HISTORY Father died at 75 of emphysema Mother had coronary artery bypass surgery at age 68 MEDICAL HISTORY Jane is following the AHA guidelines for diet and exercise Postmenopausal
AGE 55 WEIGHT 147 HEIGHT 5' 3" WAIST 34" BMI 26.0 kg/m2		Projected lipid results with TriCor † Lipid Parameter (mg/dL) Baseline Improvement Projected Results LDL-C 130 20% 104 HDL-C 44 15% 51 TG 225 36% 144 Total Cholesterol 219 17% 182 Non-HDL-C (calc) 175 131

	Mark Williams *    PATIENT   FAMILY HISTORY Family history of type 2 diabetes on father's side Mother is in good health MEDICAL HISTORY Mark is following the South Beach Diet™ and joined a gym He stopped smoking 6 months ago
AGE 65 WEIGHT 235 HEIGHT 6' 1" WAIST 43" BMI 31.0 kg/m2		Projected lipid results with TriCor † Lipid Parameter (mg/dL) Baseline Improvement Projected Results LDL-C 135 20% 108 HDL-C 36 15% 41 TG 234 36% 150 Total Cholesterol 218 17% 181 Non-HDL-C (calc) 182 140

* Jane Duncan and Mark Williams are not actual patients.

†Individual results may vary. Hypothetical patient results are based on 4 randomized, placebo-controlled, double-blind, parallel-group studies including type IIb patients (N=242) with the following mean baseline lipid values: Total-C 312.8 mg/dL; LDL-C 219.8 mg/dL; HDL-C 46.7 mg/dL; and TG 231.9 mg/dL. Patients were randomized to either fenofibrate (n=126) at a dose equivalent to 145 mg TriCor per day or placebo (n=116). Duration of study treatment was 3 to 6 months. P<0.05 vs placebo. (1)

Reference

1. TriCor tablets package insert, Abbott Laboratories.